<DOC>
	<DOC>NCT01162161</DOC>
	<brief_summary>In this mono-center prospective study, the impact of changes in the sphingolipid metabolism in patients with pulmonary edema will be investigated.</brief_summary>
	<brief_title>Role of Sphingolipids in Pulmonary Edema</brief_title>
	<detailed_description>There will be three groups of patients: 1. hydrostatic pulmonary edema 2. toxic pulmonary edema 3. not ventilated patients without any pulmonary edema Samples of a routine bronchoalveolar lavage and EDTA-blood will be analysed in respect of sphingolipids, ceramide, sphingomyelin-phosphodiesterase and several cytokines.</detailed_description>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Pulmonary Edema</mesh_term>
	<criteria>above the age of 18 taking steroids</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>sphingolipid</keyword>
	<keyword>ceramide</keyword>
	<keyword>sphingomyelinase</keyword>
</DOC>